A newborn screening method for cerebrotendinous xanthomatosis using bile alcohol glucuronides and metabolite ratios.

MLA

Vaz, Frédéric M., et al. “A Newborn Screening Method for Cerebrotendinous Xanthomatosis Using Bile Alcohol Glucuronides and Metabolite Ratios.” Journal of Lipid Research, vol. 58, no. 5, May 2017, pp. 1002–07. EBSCOhost, https://doi.org/10.1194/jlr.P075051.

APA

Vaz, F. M., Bootsma, A. H., Kulik, W., Verrips, A., Wevers, R. A., Schielen, P. C., DeBarber, A. E., & Huidekoper, H. H. (2017). A newborn screening method for cerebrotendinous xanthomatosis using bile alcohol glucuronides and metabolite ratios. Journal of Lipid Research, 58(5), 1002–1007. https://doi.org/10.1194/jlr.P075051

Chicago

Vaz, Frédéric M, Albert H Bootsma, Willem Kulik, Aad Verrips, Ron A Wevers, Peter C Schielen, Andrea E DeBarber, and Hidde H Huidekoper. 2017. “A Newborn Screening Method for Cerebrotendinous Xanthomatosis Using Bile Alcohol Glucuronides and Metabolite Ratios.” Journal of Lipid Research 58 (5): 1002–7. doi:10.1194/jlr.P075051.